RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BOFFA L
Collezione AOU San Luigi di Orbassano

Items : 4

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Cocco E; Gasperini C; Solaro C; Gazzola P; Gallo A; Maniscalco GT; Paolicelli D; Calabrese M; Borrelli A; Tomassini V; De Luca G; Clerico M; Boffa L; Lanzillo R; Moccia M; Ferraro D; Gajofatto A; Prosperini L; Fantozzi R; Buttari F; Laroni A; Lorefice L; Radaelli M; Nociti V; Torri Clerici V; Cavalla P; Annovazzi P; Malucchi S; et alii...

Informing MS patients on treatment options: a consensus on the process of consent taking. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Aug;41(8):2249-2253. doi: 10.1007/s10072-020-04339-z. Epub 2020 Apr 2.

2020
AOU San Luigi di Orbassano

Tortorella C; Solaro C; Annovazzi P; Boffa L; Buscarinu MC; Buttari F; Calabrese M; Cavalla P; Cocco E; Cordioli C; De Luca G; Di Filippo M; Fantozzi R; Ferraro D; Gajofatto A; Gallo A; Lanzillo R; Laroni A; Fermo SL; Malucchi S; Maniscalco GT; Moccia M; Nociti V; Paolicelli D; Pesci I; Prosperini L; Ragonese P; Tomassini V; Clerici VLAT; et alii...

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. in Journal of neurology / J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

2018
ASL Vercelli
AOU San Luigi di Orbassano

Gajofatto A; Pesci I; Laroni A; Coghe G; Gallo A; Pinardi F; Buscarinu MC; Di Filippo M; Maniscalco GT; Ragonese P; Buttari F; Boffa L; Clerici VT; Malucchi S; Radaelli M; Cavalla P; Annovazzi P; Nociti V; Tortorella C; Fantozzi R; Moccia M; Gasperini C; Prosperini L; Lanzillo R; Calabrese M; Tomassini V; Cocco E; Solaro C;

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.

2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;